A registered study indexed because it matched monitored longevity research terms. Registry status: Completed. Registration does not establish safety or effectiveness.
What the source actually supports
- Evidence stage
- Phase not reported
- Study design
- NON RANDOMIZED · PARALLEL · BASIC SCIENCE · DOUBLE
- Evidence population
- Human clinical study registration
- Participants
- 44
- Population
- MALE · 63 Years to 75 Years
- Duration
- 2017-09-01 to 2018-05-30
- Intervention
- Instantized Whey Protein Isolate
- Comparator
- Low systemic inflammation
- Outcomes measured
- Systemic inflammation — At baseline.; Change in muscle protein synthesis (MPS) — At baseline and 180 min following protein ingestion.; Change in intracellular signaling proteins in muscle — At baseline and 180 min following protein ingestion.; Change in proteasome activities in muscle — At baseline and 180 min following protein ingestion.; Change in protein expression level of proteasome subunits — At baseline and 180 min following protein ingestion.; Resting metabolic rate (RMR) — At baseline.; Physical activity — Over a 7-day period at baseline.; Dietary intake — Over a 7-day period at baseline.; Reduced glutathione in blood — At baseline.; Oxidized glutathione in blood — At baseline.; Protein carbonyls in serum — At baseline.; Total antioxidant capacity — At baseline.; Malondialdehyde in serum — At baseline.; White blood cell count in blood — At baseline.; Insulin sensitivity — At baseline.; Glucose concentration in blood — At baseline and at 30 min, 60 min, 90 min, 120 min, 150 min and 180 min following prot…; Insulin concentration in blood — At baseline and at 30 min, 60 min, 90 min, 120 min, 150 min and 180 min following prot…; Body composition — At baseline; Body Mass Index (BMI) — At baseline; Skeletal muscle index — At baseline
- Reported result
- No reusable finding-level result is available in this record.
Main limitationThis is a study registration. No reusable structured result is available here, so it cannot show whether the intervention worked or was safe.
Safety and approvalEligibility, adverse-event details, and clinical decisions must be checked in the official registry and with qualified clinicians. Trial registration is not regulatory approval and does not establish that an intervention is available.
Source supportStructured registry protocol metadata; no finding-level conclusion is generated.
Registration and recruitment status do not establish safety, efficacy, or regulatory approval.
Why this record appears here · 100% topic match
The title, summary, or source keywords matched one or more topics followed by immortal.life. A higher percentage means a stronger topic match; it does not rate safety, effectiveness, or study quality.
- Chronic inflammation · 100%Title contains controlled term: inflammaging. Abstract contains controlled term: inflammaging. Source terminology contains: inflammaging. Title supplies longevity context: aging. Study type is explicitly identified as INTERVENTIONAL.
Automated source check 100% · update recency 50%. These figures help sort records; they are not medical ratings.